docetaxel anhydrous has been researched along with 1-monooleoyl-rac-glycerol in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (1-monooleoyl-rac-glycerol) | Trials (1-monooleoyl-rac-glycerol) | Recent Studies (post-2010) (1-monooleoyl-rac-glycerol) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 610 | 0 | 278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharne, AP; Khedekar, PB; Rarokar, NR; Umekar, MJ | 1 |
1 other study(ies) available for docetaxel anhydrous and 1-monooleoyl-rac-glycerol
| Article | Year |
|---|---|
Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell line.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Docetaxel; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Epithelial Cells; Factor Analysis, Statistical; Glycerides; Humans; Kinetics; Nanoparticles; Particle Size; Poloxamer | 2019 |